Stock Earnings

Question 1

Regeneron Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Regeneron Pharmaceuticals Inc'in toplam varlıkları $37,759 olup, net profit $4,412'dir.

Question 2

REGN'ün temel finansal oranları nelerdir?

Accepted Answer

Regeneron Pharmaceuticals Inc'in cari oranı 4.49, net kâr marjı 31.06, hisse başına satış $123.38'dir.

Question 3

Regeneron Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Currently Regeneron Pharmaceuticals Inc data is not available.

Question 4

Regeneron Pharmaceuticals Inc kârlı mı?

Accepted Answer

yes, son mali tablolara göre Regeneron Pharmaceuticals Inc'in net profit $4,412'dir.

Question 5

Regeneron Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Regeneron Pharmaceuticals Inc'in yükümlülüğü 8,405'dir.

Question 6

Regeneron Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Regeneron Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 109.6'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,247	14,202	13,117	12,172	16,071	8,497
Revenue Growth (YoY)	3%	8%	8%	-24%	89%	8%
Cost of Revenue	1,955	1,844	1,713	1,301	2,205	1,119
Gross Profit	12,292	12,357	11,403	10,871	13,865	7,377
Selling, General & Admin	3,196	2,954	2,631	2,115	1,824	1,441
Research & Development	5,156	5,132	4,439	3,592	2,864	2,650
Operating Expenses	8,358	8,139	7,068	5,618	4,643	3,810
Other Non Operating Income (Expenses)	38	15	-20	219	50	94
Pretax Income	5,145	4,779	4,199	4,858	9,325	3,810
Income Tax Expense	567	367	245	520	1,250	297
Net Income	4,578	4,412	3,953	4,338	8,075	3,513
Net Income Growth	-2%	12%	-9%	-46%	130%	66%
Shares Outstanding (Diluted)	107.2	115.1	113.7	113.5	112.2	115.1
Shares Change (YoY)	-8%	1%	0%	1%	-3%	0%
EPS (Diluted)	42.7	38.34	34.77	38.22	71.97	30.52
EPS Growth	7%	10%	-9%	-47%	136%	65%
Free Cash Flow	3,881	3,538	3,667	3,398	6,529	2,003
Free Cash Flow Per Share	36.2	30.73	32.25	29.93	58.19	17.4
Gross Margin	86.27%	87%	86.93%	89.31%	86.27%	86.81%
Operating Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Profit Margin	32.13%	31.06%	30.13%	35.63%	50.24%	41.34%
Free Cash Flow Margin	27.24%	24.91%	27.95%	27.91%	40.62%	23.57%
EBITDA	4,458	4,700	4,756	5,593	9,508	3,801
EBITDA Margin	31.29%	33.09%	36.25%	45.94%	59.16%	44.73%
D&A For EBITDA	525	482	421	341	286	235
EBIT	3,933	4,218	4,335	5,252	9,222	3,566
EBIT Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Effective Tax Rate	11.02%	7.67%	5.83%	10.7%	13.4%	7.79%

Regeneron Pharmaceuticals Inc (REGN) Price